Invention Grant
US08946444B2 Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control
有权
四氢咔唑作为通过翻译控制抑制VEGF生成的活性剂
- Patent Title: Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control
- Patent Title (中): 四氢咔唑作为通过翻译控制抑制VEGF生成的活性剂
-
Application No.: US11720055Application Date: 2005-11-23
-
Publication No.: US08946444B2Publication Date: 2015-02-03
- Inventor: William Lennox , Hongyan Qi , Duck-Hyung Lee , Soongyu Choi , Young-Choon Moon
- Applicant: William Lennox , Hongyan Qi , Duck-Hyung Lee , Soongyu Choi , Young-Choon Moon
- Applicant Address: US NJ South Plainfield
- Assignee: PTC Therapeutics, Inc.
- Current Assignee: PTC Therapeutics, Inc.
- Current Assignee Address: US NJ South Plainfield
- Agency: Hoffmann & Baron, LLP
- International Application: PCT/US2005/042483 WO 20051123
- International Announcement: WO2006/065480 WO 20060622
- Main IPC: C07D209/90
- IPC: C07D209/90 ; C07D209/08 ; C07D471/04
Abstract:
The present invention relates to methods, compounds, and compositions for inhibiting angiogenesis. More particularly, the present invention relates to methods, compounds, and compositions for inhibiting VEGF production.
Public/Granted literature
- US20090042866A1 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control Public/Granted day:2009-02-12
Information query
